Pharmacologic stress echocardiography in the assessment of coronary arterydisease

Citation
E. Picano et Mg. Trivieri, Pharmacologic stress echocardiography in the assessment of coronary arterydisease, CURR OPIN C, 14(6), 1999, pp. 464-470
Citations number
47
Categorie Soggetti
Cardiovascular & Respiratory Systems
Journal title
CURRENT OPINION IN CARDIOLOGY
ISSN journal
02684705 → ACNP
Volume
14
Issue
6
Year of publication
1999
Pages
464 - 470
Database
ISI
SICI code
0268-4705(199911)14:6<464:PSEITA>2.0.ZU;2-W
Abstract
Pharmacologic stress echocardiography has gained widespread popularity in r ecent years because it is more feasible for the patient and less technicall y demanding for the echocardiographer than exercise stress testing. The two most popular pharmacologic stresses are dobutamine and dipyridamole. These agents provide similar prognostic value and diagnostic accuracy for angiog raphically assessed coronary artery disease; dobutamine has marginally high er sensitivity in single-vessel disease, and dipyridamole has marginally hi gher specificity in patients with normal coronary arteries. Both stresses a re safe, but a physician should always be in attendance when they are admin istered: Life-threatening reactions can occur in one of 300 to 500 cases wi th dobutamine and in one of 700 to 1500 cases with dipyridamole, For dipyri damole and dobutamine echocardiography, outcome data are available from mul ticenter, international, observational, prospective studies, such as the EP IC (Echo Persantine International Cooperative) and EDIC (Echo Dobutamine in ternational Cooperative) studies. (C) 1999 Lippincott Williams & Wilkins, I nc.